SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-022402
Filing Date
2019-11-07
Accepted
2019-11-07 17:22:46
Documents
53
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k110619_therapixbioscience.htm 6-K 14797
2 PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON NOVEMBER 7, 2019, TITLED ?T f6k110619ex99-1_therapixbio.htm EX-99.1 8592
3 THERAPIX BIOSCIENCES LTD.'S UNAUDITED CONSOLIDATED INTERIM FINANCIAL STATEMENTS f6k110619ex99-2_therapixbio.htm EX-99.2 384511
4 THERAPIX BIOSCIENCES LTD.'S MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO f6k110619ex99-3_therapixbio.htm EX-99.3 57265
  Complete submission text file 0001213900-19-022402.txt   2598172

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE trpx-20190630.xml EX-101.INS 432136
6 XBRL SCHEMA FILE trpx-20190630.xsd EX-101.SCH 52545
7 XBRL CALCULATION FILE trpx-20190630_cal.xml EX-101.CAL 49755
8 XBRL DEFINITION FILE trpx-20190630_def.xml EX-101.DEF 96124
9 XBRL LABEL FILE trpx-20190630_lab.xml EX-101.LAB 268256
10 XBRL PRESENTATION FILE trpx-20190630_pre.xml EX-101.PRE 185181
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 191201386
SIC: 2834 Pharmaceutical Preparations